Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Tata India Pharma & Healthcare Fund | ICICI Prudential Conglomerate Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Tata | ICICI Pru |
| AUM | ₹1,534 Cr | ₹811 Cr |
| NAV | ₹38.9215 | ₹10.5300 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | — | 1.1 years |
| Expense ratio | 1.1% | 1.4% |
| Stars | Not rated | Not rated |
| Growth Score | — | — |
AUM: AMFI's average assets under management for July - September 2026, in ₹ crore, for the whole fund (Direct and Regular, Growth and IDCW added up). The same source and period for every fund, so the figures compare.
Returns
| Tata India Pharma & Healthcare Fund | ICICI Prudential Conglomerate Fund | |
|---|---|---|
| 1 month | — | +8.22% |
| 3 months | — | −1.13% |
| 6 months | — | +5.83% |
| YTD | — | +4.46% |
| 1 year | — | +5.41% |
| 3 years (CAGR) | — | — |
| 5 years (CAGR) | — | — |
| 10 years (CAGR) | — | — |
| Since launch | — | +4.87% |
Risk
| Tata India Pharma & Healthcare Fund | ICICI Prudential Conglomerate Fund | |
|---|---|---|
| Volatility | — | — |
| Downside volatility | — | — |
| Sharpe | — | — |
| Sortino | — | — |
| Calmar | — | — |
| Return / risk | — | — |
| Deepest fall | — | −14.08% |
| Days to recover | — | 45 |
| Below its high | — | −2.59% |
Against benchmark
| Tata India Pharma & Healthcare Fund | ICICI Prudential Conglomerate Fund | |
|---|---|---|
| Alpha | — | — |
| Beta | — | — |
| R² | — | — |
| Up capture | — | — |
| Down capture | — | — |
| Tracking error | — | — |
| Information ratio | — | — |
| Treynor | — | — |
Consistency
| Tata India Pharma & Healthcare Fund | ICICI Prudential Conglomerate Fund | |
|---|---|---|
| Best 1-year | — | — |
| Middle 1-year | — | — |
| Worst 1-year | — | — |
| 1-year periods with a loss | — | — |
| Middle 3-year | — | — |
| Positive months | — | — |
| Best day | — | +5.09% |
| Worst day | — | −3.88% |
| Worst 5% day | — | −1.76% |
| Positive days | — | 51.9% |
| NAVs a year | — | 247 |
SIP of ₹10,000 a month
| Tata India Pharma & Healthcare Fund | ICICI Prudential Conglomerate Fund | |
|---|---|---|
| 5-year XIRR | — | — |
| 5-year value | — | — |
| 3-year XIRR | — | — |
| 1-year XIRR | — | +9.04% |
Holdings overlap i
| Tata India Pharma & Healthcare Fund | ICICI Prudential Conglomerate Fund | |
|---|---|---|
| Tata India Pharma & Healthcare Fund Direct · filing Oct 2026 | — | 0% |
| ICICI Prudential Conglomerate Fund Direct · filing Oct 2026 | 0% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Tata India Pharma & Healthcare Fund and ICICI Prudential Conglomerate Fund
Overlap
0.3%
smaller weight of each shared stock, added up
Stocks in common
1
of 39 and 41
Weight in common
1% · 0%
of each fund's money
Filings compared
Oct 2026 · Oct 2026
same month
| Common stock | Tata India Pharma & Healthcare Fund | ICICI Prudential Conglomerate Fund | Counts toward overlap |
|---|---|---|---|
| Gujarat Fluorochemicals Limited | 0.51% | 0.27% | 0.27% |
| 1 stocks | 0.5% | 0.3% | 0.3% |
Only in Tata India Pharma & Healthcare Fund (38)
| Sun Pharmaceutical Industries Limited | 7.89% |
| Abbott India Limited | 5.66% |
| Divi's Laboratories Limited | 5.41% |
| Healthcare Global Enterprises Limited | 5.25% |
| Dr. Reddy's Laboratories Limited | 5.14% |
| Torrent Pharmaceuticals Limited | 4.73% |
| Apollo Hospitals Enterprise Limited | 4.55% |
| Max Healthcare Institute Limited | 4.28% |
| Rainbow Childrens Medicare Limited | 4.02% |
| Sai Life Sciences Limited | 3.22% |
| Syngene International Limited | 3.17% |
| Procter & Gamble Health Limited | 3.15% |
| Lupin Limited | 3.13% |
| Cipla Limited | 3.08% |
| Anthem Biosciences Limited | 2.99% |
| Natco Pharma Limited | 2.86% |
| FDC Limited | 2.69% |
| Bayer Cropscience Limited | 2.68% |
| Acutaas Chemicals Limited | 2.40% |
| Pfizer Limited | 2.40% |
| Aster DM Quality Care Limited | 2.33% |
| Biocon Limited | 2.23% |
| Navin Fluorine International Limited | 2.15% |
| Sanofi Consumer Healthcare India Limited | 1.99% |
| Ajanta Pharma Limited | 1.59% |
and 13 smaller holdings (10.2% of the fund).
Only in ICICI Prudential Conglomerate Fund (40)
| Mahindra & Mahindra Limited | 8.49% |
| UltraTech Cement Limited | 7.14% |
| CG Power and Industrial Solutions Limited | 6.85% |
| TVS Motor Company Limited | 4.99% |
| JSW Steel Limited | 4.24% |
| Cholamandalam Investment and Finance Company Ltd | 4.00% |
| Bajaj Finance Limited | 3.94% |
| Samvardhana Motherson International Limited | 3.72% |
| APL Apollo Tubes Limited | 3.56% |
| Coromandel International Limited | 3.34% |
| JSW Infrastructure Limited | 3.01% |
| Jindal Steel Limited | 2.90% |
| Piramal Pharma Limited | 2.89% |
| Hindalco Industries Limited | 2.58% |
| Voltas Limited | 2.54% |
| Jindal Stainless Limited | 2.50% |
| Tata Steel Limited | 2.33% |
| Bharti Airtel Limited | 2.21% |
| Tata Motors Ltd | 2.11% |
| Adani Ports and Special Economic Zone Limited | 1.88% |
| Tata Motors Passenger Vehicles Limited | 1.86% |
| Zensar Technologies Limited | 1.69% |
| Carborundum Universal Limited | 1.66% |
| The Indian Hotels Company Limited | 1.61% |
| Aditya Birla Real Estate Limited | 1.45% |
and 15 smaller holdings (12.4% of the fund).
Method: from each fund's latest monthly portfolio filing, shares only (Indian and foreign equity; bonds, cash and derivatives are left out). Overlap adds up, for every stock both hold, the smaller of the two weights.
Sectors and company size
| Tata India Pharma & Healthcare Fund | ICICI Prudential Conglomerate Fund | |
|---|---|---|
| Large companies | 26.8% | 64.5% |
| Mid companies | 30.4% | 16.8% |
| Small companies | 40.2% | 14.9% |
| Top 10 holdings | 50.1% | 50.3% |
| Largest sector | Pharmaceuticals & Biotechnology 64% | Automobiles 15% |